DailyDoctor Archive Specialties Get app
Back to the 10 October 2026 edition

Research · 02 of 05

Two in three older adults with long-standing type 1 diabetes screen at risk of sleep apnoea

Consider screening older adults with long-standing type 1 diabetes for sleep apnoea, especially those with autonomic neuropathy.

Design
Cross-sectional analysis within a long-term cohort, validated questionnaires
Population
963 adults with type 1 diabetes, mean age 64, mean duration 43 years (DCCT/EDIC)
Primary outcome
Prevalence of OSA risk (STOP-Bang ≥3), poor sleep quality and daytime sleepiness
Effect
OSA risk 64%, poor sleep 43%, sleepiness 10%; each 1% HbA1c rise linked to 15–20% higher odds of a sleep problem

Investigators from the DCCT/EDIC cohort gave validated sleep questionnaires to 963 participants with type 1 diabetes, mean age 64 and mean diabetes duration 43 years. They used STOP-Bang for apnoea risk, the Pittsburgh index for sleep quality and the Epworth scale for daytime sleepiness.

29% already had a diagnosis of obstructive sleep apnoea and 19% were using a positive airway pressure device. A further screen put 64% at intermediate or high risk. Poor sleep quality was reported by 43%. Each 1% higher HbA1c was associated with 15–20% higher odds of any sleep problem, and cardiovascular autonomic neuropathy was associated with apnoea risk after adjustment for BMI and glycaemia.

Sleep apnoea is usually thought of as a type 2 diabetes and obesity problem. This cohort suggests it is common in older people with type 1 as well, and is linked to autonomic neuropathy rather than weight alone. It is cross-sectional and questionnaire-based, so it cannot say that better glucose control would improve sleep, or which way the association runs. It is a reason to ask, not a reason to change treatment.

  • Ask older patients with long-standing type 1 diabetes about snoring, witnessed apnoeas and daytime sleepiness at the annual review.
  • STOP-Bang takes under a minute and was the screening tool used here; a score of 3 or more is intermediate or high risk.
  • Consider sleep assessment particularly where there is cardiovascular autonomic neuropathy, which was associated with higher apnoea risk.
  • Poor sleep was linked to albuminuria and severe hypoglycaemia; ask about nocturnal hypos when a patient reports broken sleep.
  • A normal BMI does not rule out sleep apnoea in this group.

Why it matters

Sleep apnoea is usually screened for in type 2 diabetes and obesity; this suggests the type 1 clinic is missing it.

Don't overread it

A STOP-Bang score is a risk screen, not a diagnosis, and the HbA1c link is an association rather than a cause.

The statistics, in plain English

'15–20% higher odds per 1% HbA1c' means the chance of reporting a sleep problem rises steadily with glucose, but this is a snapshot taken at one time. People who sleep badly may have higher HbA1c because of the poor sleep, rather than the other way round.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

glp1type2obesitytype1neuropathy

Tomorrow morning, before your first patient

One edition a day for diabetes & endocrinology, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app